The likelihood is that it will be very undersubscribed. Most...

The likelihood is that it will be very undersubscribed. Most people will run a mile given their history with Colostat and the way they have treated the shareholders. PLUS the chances of Colostat becomming a commercial success in the face of ever growing competition decreases exponentially with every year that passes.
If they offered an option that paid out based on their failure to deliver on promises I'd be backing the truck in. 12 months time, if they last that long, guarantee they come out with all the excuses in the world why they couldnt get permission from the FDA, TGA reapplication wont have been submitted (unless they just take a packet of blank Reflex paper straight from the shelf of Officeworks and submit that) and the hand will be out for even more money.